FYERS
Novateor Research Laboratories35.10
+0.00 (+0.00%)

Novateor Research Laboratories Share Price

35.10+0.00 (+0.00%)
+33.46% past 1 Year

Corporate filings & documents

Announcements

Annual Report for the Financial Year 2025-26
2 weeks ago
Annual Report for the Financial Year 2025-26
2 weeks ago
Notice of 15th Annual General Meeting of the company to be held on Tuesday September 29 2026 at 3 p.m. at the registered office of the company.
2 weeks ago
Notice of 15th Annual General Meeting of the company to be held on Tuesday September 29 2026 at 3 p.m. at the registered office of the company.
2 weeks ago
The cut off date to determine eligible shareholders who can attend the 15th AGM of the company will be Friday September 25 2026
3 weeks ago
The cut off date to determine eligible shareholders who can attend the 15th AGM of the company will be Friday September 25 2026
3 weeks ago
15th Annual General Meeting of the company will be held on Tuesday September 29 2026 at 3:00 P.M. at the registered office of the company
3 weeks ago
15th Annual General Meeting of the company will be held on Tuesday September 29 2026 at 3:00 P.M. at the registered office of the company
3 weeks ago
15th Annual General Meeting of the company will be held on Tuesday September 29 2026 at 3:00 P.M. at the registered office of the company
3 weeks ago
Appointment of Secretarial Auditor and Internal Auditor of the company for the F.Y. 2026-27
3 weeks ago
Appointment of Secretarial Auditor and Internal Auditor of the company for the F.Y. 2026-27
3 weeks ago
Outcome of Board Meeting of the Board of Directors held on Thursday September 03 2026 to interalia considered the agenda of ensuing AGM of the company and allied activities.
3 weeks ago
Outcome of Board Meeting of the Board of Directors held on Thursday September 03 2026 to interalia considered the agenda of ensuing AGM of the company and allied activities.
3 weeks ago
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 inter alia to consider and approve the agenda related to ensuing Annual General Meeting and other businesses with the permission of Chairman.
3 weeks ago
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 inter alia to consider and approve the agenda related to ensuing Annual General Meeting and other businesses with the permission of Chairman.
3 weeks ago
The company has entered into Marketer and Manufacturing Agreement with Smart Laboratories Private Limited and received Purchase order from them for 10000 units Advance Teeth Whitening Serum worth Rs. 8 40 000 excluding GST.
1 month ago
The company has entered into Marketer and Manufacturing Agreement with Smart Laboratories Private Limited and received Purchase order from them for 10000 units Advance Teeth Whitening Serum worth Rs. 8 40 000 excluding GST.
1 month ago
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended June 30 2026
1 month ago
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended June 30 2026
1 month ago
The company has launched new Product- Smiloshine Herbafresh Toothpaste formulated with 8 herbs 6 grams Sachet as on June 15 2026
3 months ago
The company has launched new Product- Smiloshine Herbafresh Toothpaste formulated with 8 herbs 6 grams Sachet as on June 15 2026
3 months ago
Approval and adoption of audited Financial Results for the half year and year ended on March 31 2026
3 months ago
Approval and adoption of audited Financial Results for the half year and year ended on March 31 2026
3 months ago
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the audited financial results for the half year and year ended on March 31 2026
4 months ago
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Novateor Research Laboratories Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24230GJ2011PLC064731</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.70</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2025-26 2026-27</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Pooja Rathi</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Navdeep Mehta</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Novateor Research Laboratories Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L24230GJ2011PLC064731</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 2026-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.70</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>0</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>0</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>0</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2025-26 2026-27</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Pooja Rathi</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Navdeep Mehta</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 30/04/2026<br/><br/></div>
4 months ago
The company has launched new product- Herbafresh Toothpaste as on April 30 2026
4 months ago
The company has launched new product- Herbafresh Toothpaste as on April 30 2026
4 months ago
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations. 2018 for the quarter ended on March 31 2026
5 months ago
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations. 2018 for the quarter ended on March 31 2026
5 months ago
Trading window for trading in the securities of the company will remain closed with effect from April 01 2026 till 48 hours after the announcement of the Financial Results for the half year and year ended on March 31 2026 for all the directors designated persons and their immediate relative(s) as per Code of Conduct for prevention of Insider trading of the company under SEBI (PIT) Regulations 2015
5 months ago
Trading window for trading in the securities of the company will remain closed with effect from April 01 2026 till 48 hours after the announcement of the Financial Results for the half year and year ended on March 31 2026 for all the directors designated persons and their immediate relative(s) as per Code of Conduct for prevention of Insider trading of the company under SEBI (PIT) Regulations 2015
5 months ago
The company has launched new product- Smiloshine Aligner and Denture Cleaner and Whitener Foam as on February 10 2026
7 months ago
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
8 months ago
Unaudited Financial Results for the half year ended on 30.09.2025
10 months ago
Meeting of Board of Directors is held today for approval Unaudited Financial Results for the half year ended on 30.09.2025
10 months ago
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Financial Results for the half year ended on September 30 2025
10 months ago
Appointment of Mrs. Pooja Rathi Bafna as Company Secretary and Compliance officer of the company w.e.f. November 03 2025
10 months ago
Non Applicability of submission of Related Party disclosures for the half year ended on September 30 2025 pursuant to Regulation 23 (9) of SEBI (LODR) Regulations 2015
11 months ago
Compliance Certificate under Regulation 74(50 of SEBI (DP) Regulations 2018 for the half year ended on September 30 2025
11 months ago
Addition of clauses in the Memorandum of Association (MOA) of the company
11 months ago
Appointment of Mr. Anil Tilakraj Arora (DIN: 03469947) as a Non Executive Independent Director of the company
11 months ago
Proceeding of 14th Annual General meeting of the company
11 months ago
Trading Window for trading in the securities of the company will remain closed with effect from October 01 2025 for all directors designated persons and their immediate relative(s). The trading window will be opened after 48 hours after the announcement of the financial results for the half year ended on September 30 2025
11 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Novateor Research Laboratories Ltd Share Price Today

The Novateor Research Laboratories Ltd share price today is ₹32.00. During the trading session, the Novateor Research Laboratories Ltd share price opened at ₹0.00 and recorded an intraday high of ₹0.00 and a low of ₹0.00. Last closing price was ₹32.00. Over the past 52 weeks, the Novateor Research Laboratories Ltd share price has ranged between ₹20.08 and ₹34.50. The current Novateor Research Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.